OpenLegislation

Article 2 Amendment of Regulation (EC) No 436/2009

United Kingdom

Original text. Later amendments are not shown.

In the first subparagraph of Article 41(1) of Regulation (EC) No 436/2009, the following points are added:

  1. (x)

    ‘treatment using a membrane technology coupled with activated carbon;

  2. (y)

    use of polyvinylimidazole-polyvinylpyrrolidone copolymers;

  3. (z)

    use of silver chloride.’